Wang C#, Wei Z#, Chen K, Ye F, Yu C, Bennett V, and Zhang M*. (2014). Structural basis of diverse membrane target recognitions by ankyrins. eLife. 3:e04353..2021, Lorenzo DN, Healy JA, Hostettler J, Davis J, Yang J, Wang C, Hohmeier HE, Zhang M, and Bennett V. (2015). Ankyrin-B metabolic syndrome: age-dependent adiposity combined with primary pancreatic beta-cell insufficiency. J Clin Invest. 125(8):3087-3102..2021, Chen K#, Li J#, Wang C, Wei Z, and Zhang M. (2017). Autoinhibition of ankyrin-B/G membrane target bindings by intrinsically disordered segments from the tail regions. eLife. 6:e29150..2021, Wang C, Yu C, Ye F, Wei Z*, and Zhang M*. (2012). Structure of the ZU5-ZU5-UPA-DD tandem of ankyrin-B reveals interaction surfaces necessary for ankyrin function. PNAS. 109 (13):4822-4827..2021, Jiang H#, He H#, Chen Y#, Huang W, Cheng J, Ye J, Wang A, Tao J, Wang C, Liu Q, Jin T, Jiang W*, Deng X*, and Zhou R*. (2017). Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J Exp Med. 214(11):3219-3238..2021, Zhu W#, Wang C#, Hu J#, Wan R, Yu J, Xie J, Ma J, Guo L, Ge J, Qiu Y, Chen L, Liu H, Yan X, Liu X, Ye J, He W, Shen Y, Wang C, Mohler PJ*, and Hong K*. (2018). Ankyrin-B Q1283H variant linked to arrhythmias via loss of local protein phosphatase 2A activity causes ryanodine receptor hyperphosphorylation. Circulation. 138(23):2682-2697..2021, Lin L, Shi Y, Wang M, Wang C, Zhu J*, and Zhang R*. (2019). Rab35/ACAP2 and Rab35/RUSC2 Complex Structures Reveal Molecular Basis for Effector Recognition by Rab35 GTPase. Structure. 27(5):729-740..2021, Nelson AD, Caballero-Florán RN, Rodríguez Díaz JC, Hull JM, Yuan Y, Li J, Chen K, Walder KK, Lopez-Santiago LF, Bennett V, McInnis MG, Isom LL, Wang C, Zhang M, Jones KS, and Jenkins PM*. (2020). Ankyrin-G regulates forebrain connectivity and network synchronization via interaction with GABARAP. Mol Psychiatry. 25(11):2800-2817..2021, He H#, Jiang H#, Chen Y#, Ye J, Wang A, Wang C, Liu Q, Liang G, Deng X*, Jiang W*, and Zhou R*. (2018). Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun. 9(1):2550..2021, Huang Y, Wang H, Hao Y, Lin H, Dong M, Ye J, Song L, Wang Y, Li Q, Shan B, Jiang Y, Li H, Shao Z, Kroemer G, Zhang H, Bai L, Jin T, Wang C, Ma Y, Cai Y, Ding C, Liu S*, Pan Y*, Jiang W*, and Zhou R*. (2020). Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity. Nat Cell Biol. 22(6):716-727..2021,